66 related articles for article (PubMed ID: 38326897)
1. Trends in central nervous system-active polypharmacy among people with multiple sclerosis.
Naizer H; Wozny J; Krause TM; Huson E; Freeman L
Mult Scler; 2024 May; ():13524585241251986. PubMed ID: 38751229
[TBL] [Abstract][Full Text] [Related]
2. Polypharmacy Among Privately Insured Adults with Cerebral Palsy: A Retrospective Cohort Study.
Whitney DG; Schmidt M; Peterson MD; Haapala H
J Manag Care Spec Pharm; 2020 Sep; 26(9):1153-1161. PubMed ID: 32857655
[TBL] [Abstract][Full Text] [Related]
3. Demographics, Symptoms, Psychotropic Use, and Caregiver Distress in Patients With Early vs Late Onset Dementia.
Lee DR; Romero T; Serrano K; Panlilio M; Rojas-Parra A; Matsuno L; Mendez MF; Willinger C; Reuben DB
Am J Geriatr Psychiatry; 2024 Mar; ():. PubMed ID: 38600005
[TBL] [Abstract][Full Text] [Related]
4. Polypharmacy and associated factors in South Korean elderly patients with dementia: An analysis using National Health Insurance claims data.
Kim HL; Lee HJ
PLoS One; 2024; 19(4):e0302300. PubMed ID: 38662655
[TBL] [Abstract][Full Text] [Related]
5. Atrial Fibrillation and Other Cardiovascular Factors and the Risk of Dementia: An Italian Case-Control Study.
Mazzoli R; Chiari A; Vitolo M; Garuti C; Adani G; Vinceti G; Zamboni G; Tondelli M; Galli C; Costa M; Salemme S; Boriani G; Vinceti M; Filippini T
Int J Environ Res Public Health; 2024 May; 21(6):. PubMed ID: 38928935
[TBL] [Abstract][Full Text] [Related]
6. Use of Chronic Prescription Medications and Prevalence of Polypharmacy in Survivors of Childhood Cancer.
Ewig CLY; Cheng YM; Li HS; Wong JCL; Cho AHY; Poon FMH; Li CK; Cheung YT
Front Oncol; 2021; 11():642544. PubMed ID: 33869032
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and trends in polypharmacy and excessive polypharmacy: a retrospective national database analysis (2012-2021).
Van der Linden L; Tournoy J
Int J Clin Pharm; 2024 May; ():. PubMed ID: 38704778
[TBL] [Abstract][Full Text] [Related]
8. Trends and disparities in the prevalence of physical activity among US adults with epilepsy, 2010-2022.
Zhang J; Yu Y; Chen Z; Wang Y
Epilepsy Behav; 2024 May; 157():109850. PubMed ID: 38820682
[TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of medication counting methods to assess polypharmacy in medico-administrative databases.
Gagnon ME; Mésidor M; Simard M; Chiu YM; Gosselin M; Candas B; Sirois C
Res Social Adm Pharm; 2024 May; ():. PubMed ID: 38797631
[TBL] [Abstract][Full Text] [Related]
10. Expeditions in Epidemiologic Studies of New Onset Epilepsy in Older Adults: Stake Your Claims.
Martin RC
Epilepsy Curr; 2017; 17(6):368-369. PubMed ID: 29217982
[No Abstract] [Full Text] [Related]
11. Correction to: Trends in the Prevalence of Multiple Chronic Conditions Among US Adults With Hypertension From 1999-2000 Through 2017-2020.
Am J Hypertens; 2024 Jun; ():. PubMed ID: 38896812
[No Abstract] [Full Text] [Related]
12. Prevalence of Central Nervous System-Active Polypharmacy Among Older Adults With Dementia in the US.
Maust DT; Strominger J; Kim HM; Langa KM; Bynum JPW; Chang CH; Kales HC; Zivin K; Solway E; Marcus SC
JAMA; 2021 Mar; 325(10):952-961. PubMed ID: 33687462
[TBL] [Abstract][Full Text] [Related]
13. Secular Trends in Central Nervous System-Active Polypharmacy Among Serial Cross-Sections of US Adults, 2009-2020.
Terman SW; Niznik JD; Growdon ME; Gerlach LB; Burke JF
Drugs Aging; 2023 Oct; 40(10):941-951. PubMed ID: 37695395
[TBL] [Abstract][Full Text] [Related]
14. Polypharmacy in patients with epilepsy: A nationally representative cross-sectional study.
Terman SW; Aubert CE; Hill CE; Maust DT; Betjemann JP; Boyd CM; Burke JF
Epilepsy Behav; 2020 Oct; 111():107261. PubMed ID: 32629416
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of psychotropic polypharmacy in nursing home residents with dementia: a meta-analysis.
Jester DJ; Molinari V; Zgibor JC; Volicer L
Int Psychogeriatr; 2021 Oct; 33(10):1083-1098. PubMed ID: 33407955
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and trend of central nervous system-active medication polypharmacy among US commercially insured adults with vs without early-onset dementia: a multi-year cross-sectional study.
Wei YJ; Shrestha N; Chiang C; DeKosky ST
Alzheimers Res Ther; 2024 Feb; 16(1):30. PubMed ID: 38326897
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
